Discover the role of biomarkers in diagnosing and managing Inflammatory Bowel Disease (IBD), including Crohn's Disease and Ulcerative Colitis.
Vous n'êtes pas connecté
Researchers compare the therapeutic efficacy of risakizumab and ustekinumab for the treatment of moderate-to-severe Crohn’s disease.
Discover the role of biomarkers in diagnosing and managing Inflammatory Bowel Disease (IBD), including Crohn's Disease and Ulcerative Colitis.
A chronic inflammatory disorder of the gastrointestinal (GI) tract, inflammatory bowel disease (IBD) includes Crohn's disease (CD) and...
Researchers at UC San Francisco have developed a groundbreaking approach to treating Parkinson’s disease with a new type of brain implant called...
Researchers at UC San Francisco have developed a groundbreaking approach to treating Parkinson’s disease with a new type of brain implant called...
A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...
A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...
REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance...
REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance...
REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance...
REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance...